True Private Wealth Advisors Editas Medicine, Inc. Transaction History

True Private Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$28.06 - $37.16 $11,224 - $14,863	-400 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$14.88 - $32.78 $5,074 - $11,177	341 Added 577.97%	400 $7,000
Q4 2019 Jan 27, 2020	BUY	$19.49 - $32.63 $1,149 - $1,925	59 New	59 $1,000
Q3 2019 Oct 09, 2019	SELL	$22.49 - $26.81 $1,326 - $1,581	-59 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$20.48 - $27.76 $1,208 - $1,637	59 New	59 $1,000
Q4 2018 Jan 14, 2019	SELL	$18.19 - $31.79 $78,198 - $136,665	-4,299 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$27.65 - $38.39 $118,867 - $165,038	4,299 New	4,299 $0

252

58.7M

494K

417K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $247M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.